209 related articles for article (PubMed ID: 33421049)
1. Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice.
Zhao ZZ; Wang XL; Xie J; Chen LP; Li Q; Wang XX; Wang JF; Deng XM
Med Sci Monit; 2021 Jan; 27():e926820. PubMed ID: 33421049
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction.
Zhang Y; Zhou Y; Lou J; Li J; Bo L; Zhu K; Wan X; Deng X; Cai Z
Crit Care; 2010; 14(6):R220. PubMed ID: 21118528
[TBL] [Abstract][Full Text] [Related]
3. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].
Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression.
Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z
Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183
[TBL] [Abstract][Full Text] [Related]
5. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
Li W; Tu J; Liu X; Yang W
Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model.
Zhu W; Bao R; Fan X; Tao T; Zhu J; Wang J; Li J; Bo L; Deng X
Mediators Inflamm; 2013; 2013():361501. PubMed ID: 24324295
[TBL] [Abstract][Full Text] [Related]
7. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
Hu YM; Hsiung YC; Pai MH; Yeh SL
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Blockade Improves Survival in Sepsis by Reversing Monocyte Dysfunction and Immune Disorder.
Yang L; Gao Q; Li Q; Guo S
Inflammation; 2024 Feb; 47(1):114-128. PubMed ID: 37776443
[TBL] [Abstract][Full Text] [Related]
9. Immuno-PET Imaging of
Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
[TBL] [Abstract][Full Text] [Related]
10. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells].
Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.
Chang KC; Burnham CA; Compton SM; Rasche DP; Mazuski RJ; McDonough JS; Unsinger J; Korman AJ; Green JM; Hotchkiss RS
Crit Care; 2013 May; 17(3):R85. PubMed ID: 23663657
[TBL] [Abstract][Full Text] [Related]
12. Imaging diagnosis and efficacy monitoring by [
He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C
Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149
[No Abstract] [Full Text] [Related]
13. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
14. MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice.
Zhen J; Chen W
Biomed Pharmacother; 2018 Jan; 97():1479-1485. PubMed ID: 29793310
[TBL] [Abstract][Full Text] [Related]
15. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
16. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis.
Wang JF; Wang YP; Xie J; Zhao ZZ; Gupta S; Guo Y; Jia SH; Parodo J; Marshall JC; Deng XM
Blood; 2021 Sep; 138(9):806-810. PubMed ID: 34473230
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the Response of PD-L1 Expression to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Nonsmall-Cell Lung Cancer Xenografts by Immuno-PET Imaging.
Li D; Zou S; Cheng S; Song S; Wang P; Zhu X
Mol Pharm; 2019 Aug; 16(8):3469-3476. PubMed ID: 31283253
[TBL] [Abstract][Full Text] [Related]
18. Atezolizumab alleviates the immunosuppression induced by PD‑L1‑positive neutrophils and improves the survival of mice during sepsis.
Chen J; Chen R; Huang S; Zu B; Zhang S
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33655320
[TBL] [Abstract][Full Text] [Related]
19. Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.
von Knethen A; Schäfer A; Kuchler L; Knape T; Christen U; Hintermann E; Fißlthaler B; Schröder K; Brandes RP; Genz B; Abshagen K; Pützer BM; Sha LK; Weigert A; Syed SN; Schulz M; Shah AM; Ernst A; Putyrski M; Finkelmeier F; Pesic M; Greten F; Hogardt M; Kempf VAJ; Gunne S; Parnham MJ; Brüne B
Theranostics; 2019; 9(7):2003-2016. PubMed ID: 31037153
[TBL] [Abstract][Full Text] [Related]
20. [Effects and molecular mechanism of histone methyltransferase enhancer of zeste homolog 2 on regulating sepsis-induced T cell dysfunction].
Li Z; Zhao D; Zhou X; Tang L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):357-361. PubMed ID: 35692198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
